Automate Your Wheel Strategy on CRMD
With Tiblio's Option Bot, you can configure your own wheel strategy including CRMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CRMD
- Rev/Share 1.7884
- Book/Share 3.248
- PB 3.4144
- Debt/Equity 0.002
- CurrentRatio 7.8225
- ROIC 0.2208
- MktCap 827786279.0
- FreeCF/Share 0.4477
- PFCF 27.2208
- PE 14.7249
- Debt/Assets 0.0017
- DivYield 0
- ROE 0.4273
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 3
- DCF Score 1
- P/B Score 2
- D/E Score 2
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
Downgrade | CRMD | D. Boral Capital | Buy | Hold | -- | -- | June 30, 2025 |
Initiation | CRMD | H.C. Wainwright | -- | Buy | -- | $20 | June 30, 2025 |
Initiation | CRMD | Leerink Partners | -- | Outperform | -- | $18 | March 7, 2025 |
Initiation | CRMD | D. Boral Capital | -- | Buy | -- | $15 | Jan. 13, 2025 |
Initiation | CRMD | Rodman & Renshaw | -- | Buy | -- | $13 | Aug. 26, 2024 |
News
CorMedix Inc. (CRMD) Q4 2024 Earnings Call Transcript
Published: March 25, 2025 by: Seeking Alpha
Sentiment: Neutral
CorMedix Inc. (NASDAQ:CRMD ) Q4 2024 Earnings Conference Call March 25, 2025 8:30 AM ET Company Participants Dan Ferry - Managing Director, LifeSci Advisors Joe Todisco - Chief Executive Officer Matt David - Executive Vice President and Chief Financial Officer Erin Mistry - Executive Vice President and Chief Commercial Officer Liz Hurlburt - Executive Vice President, Chief Clinical Strategy and Operations Officer Conference Call Participants Roanna Ruiz - Leerink Partners Jason Butler - Citizens JMP Anish Nikhanj - RBC Capital Markets Jeevan Larson - Truist Securities John Todaro - Needham & Company Operator Good day and welcome to the CorMedix …
Read More
About CorMedix Inc. (CRMD)
- IPO Date 2010-05-13
- Website https://www.cormedix.com
- Industry Biotechnology
- CEO Joseph Todisco MBA
- Employees 64